Navigation Links
Organovo Reports 2012 Financial Results
Date:3/18/2013

se factors will have a significant impact on the computed fair value of the warrant liability. As such, the Company expects future changes in the fair value of the warrants to continue to vary significantly from quarter to quarter.

About Organovo Holdings, Inc. 
Organovo designs and creates functional, three-dimensional human tissues for medical research and therapeutic applications. The Company is collaborating with pharmaceutical and academic partners to develop human biological disease models in three dimensions. These 3D human tissues have the potential to accelerate the drug discovery process, enabling treatments to be developed faster and at lower cost. In addition to numerous scientific publications, their technology has been featured in The Wall Street Journal, Time Magazine, The Economist, and numerous others. Organovo is changing the shape of medical research and practice. Learn more at www.organovo.com.

Safe Harbor Statement
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company's ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company's products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, clinical studies and future product commercialization; and the Company's business, research, product development, regulatory approval, market
'/>"/>

SOURCE Organovo Holdings, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Organovo Holdings, Inc. announces redemption of 2.9 million outstanding warrants
2. Organovo and OHSU Knight Cancer Institute Announce Collaboration in Cancer Research
3. Market Boosted by Strong Tech Earnings: Bank of America Corp., MAP Pharmaceuticals Inc., Swingplane Ventures Inc., World Moto, Inc., Organovo Holdings, Inc.
4. Organovo Reports Q2 2012 Financial Results, Provides Business Update
5. Organovo, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
6. Organovo Announces Two Issued Patents, First Company Patent and Key Founder Patent
7. Organovo Holdings Appoints James T. Glover to Board of Directors
8. China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2012
9. Orexigen Therapeutics Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2012
10. Isis Pharmaceuticals Reports Clinical Data Showing Blunting of Severe Increases in CRP Following Endotoxin Challenge With ISIS-CRP Rx
11. Addus HomeCare Reports Fourth Quarter 2012 Results Completes Sale of Home Health Assets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... -- Research and Markets ( ... "Investigation Report on China,s Progesterone Market, 2010-2019" ... clinical demand for steroid drug is increasing fast ... especially its extended use in regulating human endocrine ... Progesterone, a natural progestogen produced by the corpus ...
(Date:9/3/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/tzzq39/investigation ) ... on China,s Trastuzumab Market, 2010-2019" report to their ... by FDA to be used in the clinic in ... major product of Roche. In 2013, the sales value ... After entering China in ...
(Date:9/3/2015)... UNION CITY, Calif. , Sept. 3, 2015 /PRNewswire/ ... company manufacturing point-of-care blood instrumentation and consumables to the ... Ross Taylor , chief financial officer, will present at ... Conference 2015 on Thursday, September 10, 2015 at 11:00 ... Omni Berkshire Place Hotel in New York ...
Breaking Medicine Technology:China Progesterone Market Investigation Report 2015-2019 2Investigation Report on China's Trastuzumab (Genentech) Market, 2010-2019 2
... Holdings, Inc. (NYSE and SIX: ZMH), a global leader ... in the 2011 Morgan Stanley Global Healthcare Unplugged Conference ... September 13, 2011, at 9:10 a.m. Eastern Time. ... be accessed via Zimmer,s Investor Relations website at ...
... Sept. 1, 2011 Hill-Rom Holdings, Inc., (NYSE: ... management presentation at the Morgan Stanley Global Healthcare Conference ... 8:35 a.m. ET. You are invited to ... at http://ir.hill-rom.com/events.cfm or access it directly at ...
Cached Medicine Technology:Zimmer Holdings to Present at 2011 Morgan Stanley Global Healthcare Unplugged Conference 2
(Date:9/3/2015)... ... 2015 , ... Topical BioMedics, Inc., hosted Amsterdam resident Max ... 10,000 mile journey from Santiago, Chile to Times Square and then Rhinebeck, New ... Americas” project—Max crossed six countries in 168 days on his 39-year-old Moto Guzzi ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... be situated at 4400 Columbine Drive in Bellingham, Washington. Silverado Bellingham, a 41,000 ... been carefully designed to serve up to 80 people living with Alzheimer’s, dementia ...
(Date:9/3/2015)... SAN FRANCISCO, CA (PRWEB) , ... September 03, ... ... is transforming the real estate investment landscape by connecting accredited and institutional investors ... mezzanine financing products designed to meet demand from both investors and ...
(Date:9/3/2015)... , ... September 03, 2015 , ... ... Intellicure, Inc., in its Annual Inc. 5000 list of fastest-growing private companies ... "only a tiny fraction of the nation's companies have demonstrated such remarkably consistent ...
(Date:9/3/2015)... ... ... Global Vision , the world leader in the development of innovative ... inspection solutions, ScanProof and ArtProof at Packaging Innovations 2015. , Join ... , Be the first to get a sneak peek of Intelligent Proofreading. Global Vision’s ...
Breaking Medicine News(10 mins):Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 2Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 3Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 4Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 5Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 6Health News:Site Dedication Ceremony to Celebrate New Silverado Memory Care Community 2Health News:RealtyShares Announces Mezzanine Financing Products 2Health News:RealtyShares Announces Mezzanine Financing Products 3Health News:Inc. 5000 Includes Intellicure, Inc., Two Years in a Row 2Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 2Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 3
... Than 33 Percent Traffic GrowthJERSEY CITY, N.J., March ... interactive marketing company that specializes in connecting health ... announced strong growth during 2008, along with significant ... site QualityHealth.com. The Company has used the down ...
... Exhibit , www.donaldverger.com PORTLAND, Maine, March 3 A ... a period of three days at the start of the ... compelled to turn his experience into something positive. , ... Verger for using his considerable talents to help the Innocence ...
... ANGELES, March 3 Dr. Brian S. Boxer Wachler, ... the Boxer Wachler Vision Institute in Beverly Hills, California, ... that uses vitamin applications to treat Keratoconus, an often ... patients. Dr. Boxer Wachler,s new treatment, C3-R(R) (corneal ...
... caused by faulty signalling in the brain, according to ... Psychiatry . In the biggest study of its kind, ... people with the condition have identified 49 genes that ... to controls. , Many of these genes are involved ...
... premier surgical and medical equipment supplier, now sells its DRE Integra AV-S ... be utilized as patients attempt to breathe spontaneously. , ... (Vocus) March ... of the Year by Business First of Louisville, continues expanding its ...
... scientists receive prestigious research fellowships worth US$1.5 million each , ... ... scientists have been awarded research grants from the National Research Foundation ... Singapore. These scientists hail from six nations including China, Estonia, ...
Cached Medicine News:Health News:Marketing Technology Solutions Announces Strong 2008 Growth and Web Site Enhancements for QualityHealth.com 2Health News:Victim of Mistaken Identity, Critically Acclaimed Photographer and Museum Founder to Hold Benefit for the Innocence Project 2Health News:Victim of Mistaken Identity, Critically Acclaimed Photographer and Museum Founder to Hold Benefit for the Innocence Project 3Health News:Victim of Mistaken Identity, Critically Acclaimed Photographer and Museum Founder to Hold Benefit for the Innocence Project 4Health News:New Vitamin Treatment Saves Patients (Including a U.S. Olympic Athlete) from Blinding Eye Disease Without Surgery 2Health News:New Vitamin Treatment Saves Patients (Including a U.S. Olympic Athlete) from Blinding Eye Disease Without Surgery 3Health News:Schizophrenia linked to signaling problems in new brain study 2Health News:DRE AV-S Ventilator Now Has Multiple Spontaneous Breathing Modes 2Health News:DRE AV-S Ventilator Now Has Multiple Spontaneous Breathing Modes 3Health News:DRE AV-S Ventilator Now Has Multiple Spontaneous Breathing Modes 4Health News:Singapore Offers Grants to Research Scientists to Start Labs Here 2Health News:Singapore Offers Grants to Research Scientists to Start Labs Here 3
... and Maximum ACT introducers represent the ... hemostasis introducers in the world. They ... introducers for use in interventional cardiology ... stenting, atherectomy, temporary pacing, endomyocardial biopsies, ...
... hemostasis introducers provide outstanding insertion ... dilator-to-sheath transitions, high kink resistance ... dual layer sheath cannula provides ... works with an extra strong ...
Bx VELOCITY Coronary Stent with HEPACOAT...
A steerable diagnostic catheter with optimal maneuverability...
Medicine Products: